USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Sigvaris AG

USPTO PatentsView assignee record - 14 granted patents across 12 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Sigvaris ranks #20,425 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 12 technology areas.

#20,425
of 49,997 US assignees by volume
Top 46%
by Innovation Score (36.5/100)
15.9
avg claims per patent
+200%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R20425 · Foreign Corporation #20,425 · 14 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MICRO 14 grants
  • MID-PACK #20,425/49,997
  • PHOTO-FINISH Shinsegae Internatio…
  • CPC-FOCUS A61F · 12 areas
  • INNOV-THIN 36.5/100
  • CLAIMS-RICH 15.9 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +200% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Shinsegae International Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Sigvaris’s 36.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Sigvaris

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Sigvaris's Innovation Score is 36.5/100 (top 46% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Sigvaris?

Each dot is one of Sigvaris’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Sigvaris’s own 15.9 claims/patent is ABOVE the 10.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Sigvaris vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 13.913.91414.1 0510152025 Granted patents (volume) Avg claims / patent Shinsegae International Inc. - 14, 1.79Shinsegae Interna…Shonan Gosei-jushi Seisakusho K.K. - 14, 9.07Shonan Gosei-jush…Shuangma Plastic Manufacturing Inc. - 14, 1Shuangma Plastic…Sick Stegmann GMBH - 14, 11.71Sick StegmannSiliconfile Technologies Inc. - 14, 12.64SiliconfileSimula Technology Inc. - 14, 10.57Simula TechnologySita Information Networking Computing UK Limited - 14, 20.86Sita Information…Sita Information Networking Computing USA, Inc. - 14, 22.64Sita Information…Sigvaris AG - 14, 15.86Sigvaris
Sigvaris vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Sigvaris's grants concentrate

Sigvaris AG is a focused PatentsView assignee: 12 CPC subclasses with 85.7% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2021 (3 grants) versus a trough of 1 in 2018. By volume, Sigvaris sits between Shinsegae International Inc. and Sita Information Networking Computing USA, Inc..

Sigvaris's three-year grant acceleration

Sigvaris AG shows 4 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Sigvaris's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Sigvaris holds 14 patents at rank #20,384, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Sigvaris

By rank, the assignees closest to #20,384 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Sigvaris's primary technology class.

Sigvaris's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 46% higher than 54% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 20172018202020212022202320242025 2
USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
Sigvaris AG patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 2 14.3%
2018 1 7.1%
2020 2 14.3%
2021 3 21.4%
2022 2 14.3%
2023 1 7.1%
2024 1 7.1%
2025partial year 2 14.3%

Which technologies does Sigvaris AG patent most?

Top 12 of 12 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Sigvaris AG's patent record in context - here's where to go next.

  • Sigvaris AG's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 85.7% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #20,425 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Sigvaris AG against Shinsegae International Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 36.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.